azenta.com (AZTA) Company Short-Term Debt

Corporate company logo of Azenta Inc (AZTA)

Azenta, Inc. (AZTA) production capacities for biomaterial storage robots are operating at full throttle, while the upgrading of fixed assets ensures stable cold chain maintenance. Its status as an exclusive provider allows the company to exercise pricing power over the largest pharmaceutical firms. This historical price chart on GURU.Markets shows the metric at 0.00. The business relies on the delivery of automated systems that ensure the preservation of valuable samples across laboratory networks.

AZTA Azenta Short-Term Debt (07/04/2022 - 10/29/2026)

Brooks Automation (AZTA) - metric breakdowns and financial figures

- stock price and consensus target price:
Stock Price Azenta|AZTA - Analyst Target Range
- market capitalization details:
Market Value Azenta, Inc.|AZTA - Business Value
- shareholders' equity book value data:
Net Assets per Single Share Azenta|AZTA - Total Stockholders' Equity|Market Value to Book Value Ratio azenta.com|AZTA - Company Total Asset Base
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Azenta, Inc.|AZTA - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital Azenta, Inc.|AZTA - Company Total Debt Obligations|Debts to Book Capitalization Azenta, Inc.|AZTA - Company Long-Term Liabilities|Company Current Liabilities Azenta
Fundamental company analysis:Azenta (AZTA)
Flagship merchandise of Brooks Automation

Azenta, Inc. (AZTA) provides critical infrastructure for the global biobank. This metric aggregates all obligations maturing within one year, determining the issuer's current solvency. Monitoring these limits eliminates the risk of covenant defaults and share price declines. The stability of total short-term debt confirms the financial resilience of the leading biomaterials custodian. The trend in total short-term debt serves as an indicator of the business's operational reliability.

Competitor analysis

Abbott - Company Short-Term Debts|Short-Term Indebtedness Thermo Fisher Scientific Inc. (TMO)|GE Healthcare Corp (GEHC) - Company Short-Term Debt|Company Short-Term Indebtedness MTD|Company Short-Term Debt Waters Corporation|Short-Term Debt bio-techne.com TECH|Company Short-Term Debt Bruker (BRKR)|Short-Term Debt Volume Varex Imaging Corp|Semler Scientific Corp - Company Current Liabilities|Amount of Current Liabilities BFLY (Butterfly Corp)|Mesa Laboratories, Inc. - Company Short-Term Debts|Short-Term Debt Volume quantum-si.com QSI|NNOX: Company Short-Term Debts|Company Current Liabilities Quanterix Corp.|Company Current Liabilities MASS|CV: Company Short-Term Loans and Borrowings|Company Short-Term Debt MaxCyte, Inc. (MXCT)|Company Current Liabilities rapidmicrobio.com RPID|Company Short-Term Debts SEER (Seer)|Hyperfine Inc (HYPR) - Short-Term Debt|FONAR Corp - Company Short-Term Debts|DXR (Daxor Corporation) - Company Short-Term Indebtedness|MDAI: Company Short-Term Debts|VIVS - Short-Term Debt Volume|ACON (Aclarion, Inc.) - Company Short-Term Debts|Company Current Liabilities Akoya (AKYA)|Company Short-Term Debts THMO|Company Short-Term Debts talis.bio (TLIS)|Company Short-Term Debt T2 Biosystems, Inc. TTOO